2020 INS Annual Meeting
Virtual Conference
October 22-23

Preliminary Program

This year's meeting theme is 'Our Digital Future: Building Networks Across Neuroscience, Technology and Ethics.' Sessions will address the many areas in which brain technologies and data concerning the brain are developed, deployed, utilized and regulated.

Registration will open later this month.

Meeting Times

All meeting activities will be conducted online and held synchronously during the timezones listed in the tables below. Session times listed throughout the agenda are U.S. Eastern Daylight Time (EDT).

DAY 1

THURSDAY, OCTOBER 22

FRIDAY, OCTOBER 23

PDT / 9:00 am-2:00 PM

EDT / 12:00-5:00 PM

ART / 1:00-6:00 PM

BRT / 1:00-6:00 PM

BST / 5:00-10:00 PM

CEST / 6:00-11:00 PM

SAST / 6:00-11:00 PM

IST / 9:30 PM-2:30 AM

KST / 1:00-6:00 AM

JST / 1:00-6:00 AM

AEST / 3:00-8:00 AM

DAY 2

FRIDAY, OCTOBER 23

SATURDAY, OCTOBER 24

PDT / 9:00 am-2:00 PM

EDT / 12:00-5:00 PM

ART / 1:00-6:00 PM

BRT / 1:00-6:00 PM

BST / 5:00-10:00 PM

CEST / 6:00-11:00 PM

SAST / 6:00-11:00 PM

IST / 9:30 PM-2:30 AM

KST / 1:00-6:00 AM

JST / 1:00-6:00 AM

AEST / 3:00-8:00 AM

Agenda Day 1

PLENARY SESSION / 12:00-1:00 pm EDT

 

Social Health and Social Justice

Examining the role neuroethics can play in fostering healthy and more just communities, this session will include a conversation and a discussion of attendees' questions and perspectives.

 

  • Nita Farahany, INS President, Duke Law School (United States)
  • Ilina Singh, INS Secretary/Treasurer, University of Oxford (United Kingdom)

 

Break / 1:00-1:30 PM EDT

 

Concurrent Sessions / 1:30-2:30 PM EDT

 

Governing Brain Data in the Infosphere

This session aims to broaden the discussion on international governance of brain data and the use of big data analytics in neuroscience. Special focus will be given to non-medical uses such as direct-to-consumer neurotechnology. The panelists will explore, among many topics, potential conflicts of data sharing and privacy; potential divergences between different stakeholder perspectives; confidentiality issues arising from data use for medical informatics and private ventures; and cultural views on mental privacy.

 

  • Ciro Colombara, Lawyer, RCZ Law Firm (Chile), Pro Bono Network of the Americas
  • Mary Lou Jepsen, Openwater (United States)
  • Rafael Yuste, Columbia University (United States)

 

Prospects for AI-Enabled Diagnostic Imaging

Long considered unrealistic, brain imaging for the purpose of psychiatric diagnosis appears more plausible with applications of artificial intelligence, leading to questions about its possibility to aid in differential diagnosis and treatment response. The following panelists will examine the state of the technology and likely challenges, the ethical concerns that may arise when applied to psychiatric diagnosis, and how diagnostic systems and conceptions of psychiatric disorders may change.

 

  • Vince Calhoun, Center for Translational Research in Neuroimaging and Data Science (United States)
  • Martha Farah, University of Pennsylvania (United States)
  • Stephanie Hare, University of Maryland, Baltimore (United States)
  • Steven Hyman, Stanley Center for Psychiatric Research at Broad Institute (United States)

 

Linking Social Justice and Brain Injuries Through Theology

Religious and theological traditions of ethics provide an opportunity to expand and enrich approaches to social justice in neuroethics, particularly in the context of brain injury and disorders of consciousness. The following panelists will examine how different religious traditions approach ethical issues surrounding brain injuries through a social justice lens.

 

  • Muhammad Mansur Ali, Cardiff University (United Kingdom)
  • Ira Bedzow, New York Medical College (United States)
  • Francisca Cho, Georgetown University (United States)
  • Patrick Smith, Duke University (United States)

 

BREAK / 2:30-3:00 PM EDT

 

CONCURRENT BREAKOUTS / 3:00-4:00 PM EDT

 

Professional Development and Networking

Small group discussions on the following frequently requested mentoring topics and professional competencies. Members are encouraged to contact staff to be considered to lead a group.

 

  • Career tracks
  • Funding and grants
  • Outreach and communication

 

CONCURRENT PRESENTATIONS / 4:00-5:00 PM EDT

 

Research Presentations

Several authors of top abstracts (from among those submitted by the July 10 deadline) will be selected to give a short presentation about their neuroethics research and area of study. The number of presentations will depend on the topics of the abstracts selected and any themes which emerge.

 

  • Selected authors will be determined by August 30 and announced in September as investigators confirm their participation.

 

 

Agenda Day 2

 

PLENARY SESSION / 12:00-1:00 pm EDT

 

Charting the Path to Ethical Neurotechnology

Neurotechnology is rapidly advancing. New consumer products and therapeutic applications of brain–computer interfaces in particular are forcing an industry to navigate ethical concerns such as data protection, consent, and accountability without clear guidelines or standards. This conversation with leaders of neurotechnology companies will examine issues raised by advancing device technologies and their potential applications, as well as look at opportunities to increase interdisciplinary collaboration.

 

  • Ana Maiques, Neuroelectrics (Spain)
  • Dan Rizzuto, Nia Therapeutics (United States)
  • Nicole Martinez-Martin, Stanford University (United States)
  • Anna Wexler, University of Pennsylvania (United States)

 

Break / 1:00-1:30 PM EDT

 

Concurrent Sessions / 1:30-2:30 PM EDT

 

Policing, Neurotechnology, and the Search for Truth

Over the past decade, brain-based methods of detecting lies and autobiographical memories have been introduced in neuroscience labs and applied police investigations in multiple countries. In this session forensic practitioners, scientists, and ethics and legal scholars will examine from their different perspectives the latest technologies — including electroencephalogram (EEG) memory detection — and debate if these tools can be applied fairly and ethically to aid accuracy and promote justice in police investigations and legal adjudication.

 

  • Nahari Galit, Bar Ilan University (Israel)
  • Federica Coppola, Columbia University (United States)
  • Emily Murphy, UC Hastings Law (United States)

 

Life and Health Decisions with Experimental Brain Implants

Trials researching effective treatments for psychiatric and neurological ailments are increasingly using experimental devices implanted into the brain to record signals and stimulate activity. After the study, the fate of the device can lead to complex dilemmas: for patients faced with uncertain risks and benefits; for investigators concerned with long-term care and outcomes; and for ethicists tasked with determining responsibility and establishing an appropriate course of care. Panelists will attempt to find consensus about patient care and device management after brain implant trials.

 

  • Helen Mayberg, Icahn School of Medicine at Mount Sinai (United States)
  • Saskia Hendriks, National Institutes of Health (United States)
  • Gabriel Lázaro-Muñoz, Baylor College of Medicine (United States)

 

Challenges of Artificial Intelligence and Neuroscience to Democracy

The possibilities offered by the combined insights of artificial intelligence and neuroscience raise profound questions for democracy. It’s critical to ask if AI–neuroscience technologies and their applications might be able to improve democracy, encourage greater participation in public discourse, jeopardize the opinion-building process, or challenge our understanding of self-governance. Leading experts in artificial intelligence, big data neuroscience, democratic theory, and social studies of science will lead an open discussion on these issues.

 

  • Alan Evans, McGill University (Canada)
  • Melanie Mitchell, Portland State University / Santa Fe Institute (United States)
  • Sheila Jasanoff, Harvard Kennedy School (United States)
  • Eric Racine, Montreal Clinical Research Institute (Canada)

 

BREAK / 2:30-3:00 PM EDT

 

Session / 3:00-4:00 PM EDT

 

Session to be determined

 

 

Plenary Session / 4:00-5:00 PM EDT

 

FRED KAVLI DISTINGUISHED NEUROETHICS LECTURE

Speaker to be Announced